AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 207 filers reported holding AMICUS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $12,000 | +9.1% | 1,307 | +1.1% | 0.00% | – |
| Q3 2019 | $11,000 | -38.9% | 1,293 | -9.4% | 0.00% | – |
| Q2 2019 | $18,000 | +157.1% | 1,427 | +203.0% | 0.00% | – |
| Q1 2019 | $7,000 | +75.0% | 471 | +10.8% | 0.00% | – |
| Q4 2018 | $4,000 | -63.6% | 425 | -54.4% | 0.00% | – |
| Q3 2018 | $11,000 | -76.1% | 931 | -68.2% | 0.00% | -100.0% |
| Q2 2018 | $46,000 | +4.5% | 2,931 | -0.2% | 0.00% | 0.0% |
| Q1 2018 | $44,000 | +528.6% | 2,936 | +565.8% | 0.00% | – |
| Q4 2017 | $7,000 | 0.0% | 441 | 0.0% | 0.00% | – |
| Q3 2017 | $7,000 | +600.0% | 441 | +290.3% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 113 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 113 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 113 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |